Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KKR & Co
KKR
|
+$705M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$675M |
| 3 |
Zoetis
ZTS
|
+$510M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$404M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$2.4B |
| 2 |
STJ
St Jude Medical
STJ
|
+$538M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$397M |
| 4 |
RTX Corp
RTX
|
+$347M |
| 5 |
Microsoft
MSFT
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.69% |
| 2 | Technology | 9.44% |
| 3 | Healthcare | 8.03% |
| 4 | Consumer Discretionary | 7.35% |
| 5 | Communication Services | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRP
3151
DELISTED
Fairpoint Communications, Inc.
FRP
| $3.64M | ﹤0.01% |
219,038
+50,637
| +30% | +$889K |
|
3152
PennyMac Financial
PFSI
$4B
| $3.63M | ﹤0.01% |
212,864
-548
| -0.3% | -$9.49K |
|
3153
Cytokinetics
CYTK
$11B
| $3.63M | ﹤0.01% |
282,311
+67,029
| +31% | +$783K |
|
3154
PhenixFIN
PFX
$88.1M
| $3.62M | ﹤0.01% |
23,548
-2,991
| -11% | -$457K |
|
3155
iShares MSCI Kokusai Fund
TOK
$255M
| $3.62M | ﹤0.01% |
62,209
| – | – |
|
3156
VanEck Preferred Securities ex Financials ETF
PFXF
$2.45B
| $3.62M | ﹤0.01% |
180,401
-31,109
| -15% | -$617K |
|
|
SAND
3157
DELISTED
Sandstorm Gold
SAND
| $3.61M | ﹤0.01% |
844,920
-49,522
| -6% | -$218K |
|
|
BCPC
3158
Balchem Corp
BCPC
$5.75B
| $3.6M | ﹤0.01% |
43,719
-49,505
| -53% | -$4.16M |
|
|
AHRT
3159
AH Realty Trust
AHRT
$515M
| $3.6M | ﹤0.01% |
259,138
-109,188
| -30% | -$1.52M |
|
3160
Atara Biotherapeutics
ATRA
$74.3M
| $3.6M | ﹤0.01% |
7,002
+4,174
| +148% | +$1.73M |
|
3161
Tootsie Roll Industries
TR
$2.99B
| $3.6M | ﹤0.01% |
125,682
-24,267
| -16% | -$696K |
|
|
BPY
3162
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $3.59M | ﹤0.01% |
161,402
-71,553
| -31% | -$1.6M |
|
3163
Aramark
ARMK
$14.8B
| $3.59M | ﹤0.01% |
134,916
-42,151
| -24% | -$1.07M |
|
3164
iShares MSCI Netherlands ETF
EWN
$630M
| $3.59M | ﹤0.01% |
133,958
+8,459
| +7% | +$216K |
|
|
BPMC
3165
DELISTED
Blueprint Medicines
BPMC
| $3.59M | ﹤0.01% |
89,668
-4,825
| -5% | -$173K |
|
3166
Standard Motor Products
SMP
$879M
| $3.58M | ﹤0.01% |
72,940
-26,299
| -27% | -$1.3M |
|
|
CCD
3167
Calamos Dynamic Convertible & Income Fund
CCD
$728M
| $3.58M | ﹤0.01% |
186,483
+7,684
| +4% | +$144K |
|
3168
Lakeland Financial Corp
LKFN
$1.55B
| $3.58M | ﹤0.01% |
83,057
-44,194
| -35% | -$1.98M |
|
|
GWB
3169
DELISTED
Great Western Bancorp, Inc.
GWB
| $3.58M | ﹤0.01% |
84,398
-142,720
| -63% | -$6.15M |
|
3170
Lesaka Technologies
LSAK
$403M
| $3.58M | ﹤0.01% |
292,431
+1,269
| +0.4% | +$15.9K |
|
|
BKS
3171
DELISTED
Barnes & Noble
BKS
| $3.57M | ﹤0.01% |
386,170
-430,823
| -53% | -$4.3M |
|
3172
Global X Social Media ETF
SOCL
$92.2M
| $3.57M | ﹤0.01% |
143,985
+11,529
| +9% | +$276K |
|
|
NCV
3173
Virtus Convertible & Income Fund
NCV
$386M
| $3.57M | ﹤0.01% |
131,977
+6,274
| +5% | +$168K |
|
3174
FirstCash
FCFS
$8.92B
| $3.56M | ﹤0.01% |
72,509
-148,299
| -67% | -$6.6M |
|
3175
Global X MSCI Argentina ETF
ARGT
$822M
| $3.56M | ﹤0.01% |
125,928
-5,811
| -4% | -$153K |
|
Similar funds
Morgan Stanley's Q1 2017 Portfolio in Review
As of Q1 2017, Morgan Stanley held 6,814 positions worth $325B, up 6.5% from $306B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q1 2017 filing shows 216 new, 2,666 increased, 3,277 reduced and 152 closed positions. Its largest new stake was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M. The largest sale was TotalEnergies, an estimated $2.4B.
By sector, the portfolio is most concentrated in Financials at 9.7% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Morgan Stanley's largest Q1 2017 buy was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M.
- Morgan Stanley added most to KKR & Co in Q1 2017, an estimated $705M increase.
- Morgan Stanley's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $2.4B.
- Morgan Stanley fully exited St Jude Medical in Q1 2017, selling an estimated $538M.
- Morgan Stanley's ten largest holdings make up 12% of its $325B portfolio in Q1 2017.
- Morgan Stanley opened 216 new positions and closed 152 in Q1 2017.
- Morgan Stanley's portfolio value rose 6.5% quarter-over-quarter to $325B.
Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.